- Report
- January 2024
- 200 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- February 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- February 2024
- 186 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Clinical Trials
- April 2024
- 450 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- March 2024
- 200 Pages
Global
From €3989EUR$4,150USD£3,421GBP
- Report
- January 2024
- 96 Pages
Europe
From €2388EUR$2,485USD£2,048GBP
€3412EUR$3,550USD£2,926GBP
- Report
- January 2024
- 97 Pages
Asia Pacific
From €2388EUR$2,485USD£2,048GBP
€3412EUR$3,550USD£2,926GBP
- Report
- January 2024
- 92 Pages
North America
From €2388EUR$2,485USD£2,048GBP
€3412EUR$3,550USD£2,926GBP
- Report
- January 2024
- 92 Pages
Middle East, Africa
From €2388EUR$2,485USD£2,048GBP
€3412EUR$3,550USD£2,926GBP
- Report
- September 2023
- 182 Pages
Global
From €3061EUR$3,185USD£2,625GBP
€4373EUR$4,550USD£3,750GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Clinical Trials
- April 2024
- 200 Pages
Global
€4806EUR$5,000USD£4,121GBP
- Report
- January 2024
- 82 Pages
From €2388EUR$2,485USD£2,048GBP
€3412EUR$3,550USD£2,926GBP
- Report
- April 2023
- 200 Pages
United States
From €3604EUR$3,750USD£3,091GBP
- Report
- April 2023
- 450 Pages
Global
From €3124EUR$3,250USD£2,679GBP
- Report
- April 2023
- 116 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- April 2023
- 394 Pages
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- April 2023
- 197 Pages
Global
From €3797EUR$3,950USD£3,256GBP
The Glioma Drug market is a subset of the larger Brain Cancer Drug market. Glioma is a type of brain cancer that is caused by the abnormal growth of glial cells in the brain. Treatment for glioma typically involves surgery, radiation therapy, chemotherapy, and targeted therapy. Drugs used to treat glioma include temozolomide, bevacizumab, and lomustine.
Glioma drugs are typically used in combination with other treatments, such as radiation and surgery, to improve patient outcomes. The market for glioma drugs is expected to grow due to the increasing prevalence of brain cancer and the development of new treatments.
Some companies in the Glioma Drug market include Novartis, Merck, Roche, and Pfizer. Show Less Read more